View Clinical Trial (Medical Research Study)

Greater Occipital Nerve Block for Migraine Prophylaxis - NCT00915473-85054(Clinical Trial 296939)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Phoenix
State:  
AZ
Zip Code: 85054
Conditions: Migraine Headache
Purpose: The purpose of this study is to determine whether greater occipital nerve block injection reduces the frequency of migraine headaches.
Study summary:
Criteria: Inclusion Criteria: - Age 18-75 years. - ICHD-II episodic or chronic migraine. - At least 1 attack per week. Exclusion Criteria: - Pregnant or lactating. - Continuous headache. - Maintenance opioid medication. - Started migraine prophylactic medication within the past 2 months. - Hypersensitivity to study ingredients. - Investigational medication within 90 days of screening. - Injection site infection at injection visit. - Systemic infection at injection visit. - Cranial bone defect. - Chronic cluster headache, new daily persistent headache, hemicrania continua, or chronic tension type headache.
Study is available at: Mayo Clinic
Phoenix, AZ 85054
United States

Primary Contact:
Teresa Adam
Email: radam.teresa@mayo.edu
Phone: 480-301-8756

Secondary Contact:
Teresa Radam
Email: radam.teresa@mayo.edu
Phone: 480-301-8756
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.